Ernst & Young's report on behavior change in care delivery and medical technology products. To tackle chronic diseases and tame health care costs, life sciences companies — like all health stakeholders — are moving to the behavioral change business. Changing the behaviors of patients is far from easy — you need to understand human biases and learn from behavioral economics. Life sciences companies will change their behaviors as well — to significantly extend their business models and be more patient-centric.

